Latest OncoZenge News & Updates
See the latest news and media coverage for OncoZenge. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of lozenges for oral pain in cancer patients
oncozenge.se- Headquarters
- Stockholm, Sweden
- Company type
- Public company
- Number of employees
- 5–10
Latest news about OncoZenge
Company announcements
-
OncoZenge receives conditional acceptance for BupiZenge Phase III trial
Denmark acts as RMS, with approvals from Sweden, Norway, Germany. First patient enrollment on track for Q2 2026.
-
OncoZenge invites to Annual General Meeting
Meeting on 27 May 2026 includes board elections, incentive programs, and authorizations. No dividend proposed.
-
OncoZenge calls for annual general meeting on 27 May 2026
The meeting proposes board election, incentive programme with warrants and issues. No dividends are paid.
-
OncoZenge confirms responses to EMA for BupiZenge trial
Expects CTA approval by late April or early May. Targets first patient enrolment in Q2 2026.
Media coverage
-
OncoZenge AB: OncoZenge Receives Conditional Acceptance for the Clinical Phase III Trial ('BEAM-Pain') of BupiZenge from European Authorities
OncoZenge AB (publ) ("OncoZenge" or "the Company"), a clinical-stage company developing an innovative treatment for oral pain in cancer supportive care, today announces that it...
-
OncoZenge AB: OncoZenge Reports Positive Stability Results for BupiZenge as Key Enabler for the Upcoming Phase III Trial
OncoZenge AB (publ), a pharmaceutical company developing innovative treatments for oral pain management, today announced that the three-month stability study results for its BupiZenge lozenge...
-
OncoZenge on the regulatory strategy ahead of phase III with BupiZenge - Biostock
Watch the full interview with OncoZenge's Christina Junvik below.
-
OncoZenge AB Ordinary Shares
How we make money We sell different types of products and services to both investment professionals and individual investors. These products and services are usually...
Track OncoZenge and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group
FAKRO